Literature DB >> 3731488

ELISA of 6-beta-hydroxycortisol in human urine: diurnal variations and effects of antiepileptic therapy.

A Zhiri, M Wellman-Bednawska, G Siest.   

Abstract

An enzyme-linked immunosorbent assay for urinary 6-beta-hydroxycortisol (6-beta-OHF) was developed. A highly specific antiserum against 6-beta-OHF-21-hemisuccinate bovine serum albumin (6-beta-OHF-21-HS-BSA) raised in rabbit was used. The enzyme-labelled hapten was prepared by the mixed anhydride method using horse radish peroxidase (HRP). The limit of detection is very low (10 pg), the intra-assay variation ranges from 5.2-6.6%, the inter-assay variation is 8.2-8.3%. Cross reactivities of various steroids are very low. The diurnal variations in urinary 6-beta-OHF and it's ratio to 17-hydroxycorticosteroids (17-OHCS) were studied in six healthy volunteers. No significant difference was found within the 24 h for the ratio of 6-beta-OHF to 17-OHCS. A large increase of 8-12 h urinary 6-beta-OHF was observed in patients receiving chronic treatment with antiepileptics.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731488     DOI: 10.1016/0009-8981(86)90302-5

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  7 in total

1.  Pharmacokinetics of ruboxistaurin are significantly altered by rifampicin-mediated CYP3A4 induction.

Authors:  Kwee Poo Yeo; Stephen L Lowe; Ming Tung Lim; James R Voelker; Jennifer L Burkey; Stephen D Wise
Journal:  Br J Clin Pharmacol       Date:  2006-02       Impact factor: 4.335

2.  Comparison of urinary 6beta-hydroxycortisol/cortisol ratio between neonates and their mothers.

Authors:  H Nakamura; A Hasegawa; M Kimura; S Yamagata; H Nakasa; H Osada; S Sekiya; S Ohmori; M Kitada
Journal:  Br J Clin Pharmacol       Date:  1999-01       Impact factor: 4.335

3.  The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction.

Authors:  C Ged; J M Rouillon; L Pichard; J Combalbert; N Bressot; P Bories; H Michel; P Beaune; P Maurel
Journal:  Br J Clin Pharmacol       Date:  1989-10       Impact factor: 4.335

4.  Biological monitoring of genotoxic hazard in workers of the rubber industry.

Authors:  M Moretti; M Villarini; G Scassellati-Sforzolini; S Monarca; M Libraro; C Fatigoni; F Donato; C Leonardis; L Perego
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

5.  Influence of rifampin on fleroxacin pharmacokinetics.

Authors:  J Schrenzel; P Dayer; T Leemann; E Weidekamm; R Portmann; D P Lew
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

Review 6.  Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.

Authors:  M M Galteau; F Shamsa
Journal:  Eur J Clin Pharmacol       Date:  2003-11-06       Impact factor: 2.953

7.  Study of the Urinary Ratio of 6 beta-Hydroxycortisol/Cortisol as a Biomarker of CYP3A4 Activity in Egyptian Patients with Chronic Liver Diseases.

Authors:  Ehab S Eldesoky; Sherif I Kamel; Ahlam M Farghaly; Madiha Y Bakheet; Mohsen A Hedaya; Jean-Pascal Siest
Journal:  Biomark Insights       Date:  2007-02-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.